Valuation Formosa Laboratories, Inc.

Stocks

End-of-day quote Taiwan S.E. 13/11/2026			5-day change	1st Jan Change
46.70 ^TWD	+2.08%		+6.74%	-21.25%

11-12	Formosa Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI
08-13	Formosa Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	5,085	7,275	8,839	12,266	8,274	7,131
Change	-	43.07%	21.49%	38.78%	-32.55%	-13.81%
Enterprise Value (EV) ¹	8,446	9,602	11,008	13,819	9,470	8,247
Change	-	13.69%	14.64%	25.53%	-31.47%	-12.91%
P/E	13.6x	5.86x	21.7x	97.2x	52.9x	16.3x
PBR	0.98x	0.98x	1.18x	1.62x	1.08x	0.92x
PEG	-	0x	-0.3x	-1.4x	2.2x	0x
Capitalization / Revenue	1.65x	2.32x	2.35x	2.81x	1.75x	1.47x
EV / Revenue	2.75x	3.06x	2.92x	3.17x	2x	1.7x
EV / EBITDA	18.1x	32.4x	17.6x	12.3x	7.73x	6.14x
EV / EBIT	302x	-57.2x	67.3x	20.5x	13x	10.3x
EV / FCF	-11.8x	-56.1x	47x	37.1x	-128x	20x
FCF Yield	-8.46%	-1.78%	2.13%	2.69%	-0.78%	4.99%
Dividend per Share ²	-	2	1	2	3	3
Rate of return	-	3.31%	1.36%	1.96%	4.36%	5.06%
EPS ²	3.459	10.32	3.39	1.05	1.3	3.64
Distribution rate	-	19.4%	29.5%	191%	231%	82.4%
Net sales ¹	3,075	3,142	3,766	4,360	4,731	4,851
EBITDA ¹	467.6	296.6	623.8	1,127	1,225	1,344
EBIT ¹	28.01	-168	163.5	675	725.9	803.2
Net income ¹	400	1,249	409.4	126.2	157.3	441.1
Net Debt ¹	3,361	2,327	2,169	1,553	1,196	1,115
Reference price ²	46.95	60.50	73.50	102.00	68.80	59.30
Nbr of stocks (in thousands)	108,313	120,256	120,256	120,256	120,256	120,256
Announcement Date	08/03/21	11/03/22	15/03/23	12/03/24	13/03/25	13/03/26

¹TWD in Million²TWD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
FORMOSA LABORATORIES, INC.	-	-	-	-	171M
ELI LILLY AND COMPANY	42.25x	14.3x	30.31x	0.47%	1,286B
JOHNSON & JOHNSON	41.82x	7.01x	19.73x	1.87%	688B
ABBVIE INC.	37.62x	8.63x	17.81x	2.34%	521B
ROCHE HOLDING AG	21.75x	5.27x	13.2x	2.48%	386B
MERCK & CO., INC.	104.88x	5.98x	25.49x	2.3%	364B
NOVARTIS AG	24x	5.82x	14.17x	2.73%	302B
ASTRAZENECA PLC	24.25x	4.85x	13.63x	1.8%	287B
AMGEN INC.	24.04x	7.38x	13.56x	2.17%	252B
GILEAD SCIENCES, INC.	-39.49x	7.32x	46.07x	1.96%	208B
Average	31.24x	7.40x	21.55x	2.01%	429B
Weighted average by Cap.	37.57x	8.95x	22.68x	1.68%